GLP-1 Fragment Production

• Innovative Technologies for GLP-1 Fragment Synthesis.

  The scientific community in a hobby to develop new and improved methods of generating these GLP-1 fragments. In came CRISPR, an advanced technology they are using for several innovative methodologies. CRISPR is the wonder tool that enables scientists to snip, delete and rewrite the foundational DNA of our cells; in essence a set of instructions about how they should behave.

• Steps Towards Improved GLP-1 Fragment Yield and Purity.

  However, it is not as ideal for scientists to do this each time there are new GLP-1 fragments that need dissecting. A clever way to do this is with tiny beads that can stick only where the GLP-1 bits are. These beads enable scientists to both isolate the fragments from all other biological material... The beads sift all the garbage plastic out and then they have a pure stream of GLP-1 fragments for you ladies.

• Connecting GLP-1 Fragment Production with Advancements in Diabetes Treatment.

  This week a new study adds weight to the idea that tiny fragments of GLP-1 could change diabetes treatment for good. Carbohydrates are formed of sugar molecules and therefore play significant roles in influencing blood glucose levels as well as feeding sensations of satiety, these fragments might be beneficial for individuals with diabetes. This might be a game-changer for how people self-manage their diabetes, and therefore change the lifestyle that could potentially lead to healthier life.

Why choose Yaohai GLP-1 Fragment Production?

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma has experience in the production of biologics created from GLP-1 Fragment Production. We offer customized RD and manufacturing solutions while making sure that there are no risks. We have been involved in diverse modalities such as subunit vaccines recombinant, peptides hormones, cytokines, growth factors, single-domain antibodies enzymes, plasmid DNA MRNA, and many more. We are a specialist in many microorganisms, including yeast extracellular and intracellular secretion (yields up to 15g/L) as well as bacteria intracellular soluble and inclusion body (yields as high as 10g/L). We have also created a BSL-2 fermentation platform to create bacterial vaccines. We focus on improving processes, increasing product yields, and reducing production costs. Utilizing a strong technology team, we can ensure prompt and reliable project delivery that will bring your product to market faster.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma is a Top 10 Microbial CDMO that incorporates GLP-1 Fragment Production as well as regulatory affairs. We have a quality management system which is in line with current GMP standards as well as global regulations. Our team of regulatory experts is proficient in global regulatory frameworks to accelerate biological launches. We ensure traceable production processes quality products, as well as complying with the rules of the US FDA and EU EMA. Australia TGA and China NMPA are also satisfied. Yaohai BioPharma has successfully passed the audit on site of the European Union's Qualified Person (QP) for our GMP quality system as well as our production facility. Furthermore, we have cleared the first certification audits of the ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading in GLP-1 Fragment Production CDMO. Our main focus has been the production of microbial vaccinations and therapeutics to treat pets, human and veterinary health. We possess cutting-edge RD and manufacturing technology platforms that cover the entire manufacturing process from the engineering of microbial strains, to cell banking processing and method design to clinical and commercial manufacturing, making sure that we can ensure the successful delivery of the most advanced solutions. We have accumulated a huge quantity of knowledge in the bio processing microbial field. More than 200 projects have been successfully completed and we help our clients comply with regulations like those of the US FDA as well as EU EMA. We also help them to navigate Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services due to our experience and expertise.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 producer of biological products, is a specialist in microbial fermentation. We have built an advanced facility that is equipped with advanced facilities as well as robust RD and manufacturing capabilities. Five drug substance production lines that are compliant with GMP standards for microbial purification and fermentation along with two automated fill and finishing lines for vials, cartridges and needles pre-filled are available. The scales for fermentation available are 100L, 500L, 1000L and 2000L. The filling volume ranges from 1ml to GLP-1 Fragment Production. Syringes or cartridges pre-filled are filled with the equivalent of 1-3ml. Our cGMP-compliant production workshop ensures steady supply of clinical samples and commercial products. The bulk molecules produced in our factory can be shipped worldwide.

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.